APO Research
Talk to an analyst

APO RESEARCH · REPORT

Live Cell Imaging Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Live Cell Imaging Software Market Outlook and Growth Opportunities 2026

16 January 2026190 pages

Choose your research edition.

Industry ResearchLive Cell Imaging Software Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Cell Imaging Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Live Cell Imaging Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Cell Imaging Software Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Cell Imaging Software Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Live Cell Imaging Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Live Cell Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Live Cell Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Live Cell Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Live Cell Imaging Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Live Cell Imaging Software market include Andor Technology, Fluxion Biosciences, Olympus LS, PerkinElmer, Sartorius, Molecular Devices, Phase Holographic Imaging PHI, Agilent and BioTek, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Live Cell Imaging Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Live Cell Imaging Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Live Cell Imaging Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Live Cell Imaging Software market.

Live Cell Imaging Software Segment by Company

Andor Technology

Fluxion Biosciences

Olympus LS

PerkinElmer

Sartorius

Molecular Devices

Phase Holographic Imaging PHI

Agilent

BioTek

Nanlive

CytoSMART

AutoLCI

MilliporeSigma

Live Cell Imaging Software Segment by Type

Cloud-based

On Premises

Live Cell Imaging Software Segment by Application

Laboratory

Hospital

Others

Live Cell Imaging Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Live Cell Imaging Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Live Cell Imaging Software key companies, revenue, market share, and recent developments.

3. To split the Live Cell Imaging Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Live Cell Imaging Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Live Cell Imaging Software significant trends, drivers, influence factors in global and regions.

6. To analyze Live Cell Imaging Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Cell Imaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Cell Imaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Cell Imaging Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Live Cell Imaging Software industry.

Chapter 3: Detailed analysis of Live Cell Imaging Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Live Cell Imaging Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Live Cell Imaging Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Live Cell Imaging Software Industry Trends Table 2. Live Cell Imaging Software Industry Drivers Table 3. Live Cell Imaging Software Industry Opportunities and Challenges Table 4. Live Cell Imaging Software Industry Restraints Table 5. Global Live Cell Imaging Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Live Cell Imaging Software Revenue Share by Company (2021-2026) Table 7. Global Live Cell Imaging Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Live Cell Imaging Software Key Company Manufacturing Base & Headquarters Table 9. Global Live Cell Imaging Software Company, Product Type & Application Table 10. Global Live Cell Imaging Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Live Cell Imaging Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On Premises Table 16. Global Live Cell Imaging Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Live Cell Imaging Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Live Cell Imaging Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Live Cell Imaging Software Sales Value Share by Type (2021-2026) Table 20. Global Live Cell Imaging Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Laboratory Table 22. Significant Companies of Hospital Table 23. Significant Companies of Others Table 24. Global Live Cell Imaging Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Live Cell Imaging Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Live Cell Imaging Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Live Cell Imaging Software Sales Value Share by Application (2021-2026) Table 28. Global Live Cell Imaging Software Sales Value Share by Application (2027-2032) Table 29. Global Live Cell Imaging Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Live Cell Imaging Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Live Cell Imaging Software Sales Value Share by Region (2021-2026) Table 32. Global Live Cell Imaging Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Live Cell Imaging Software Sales Value Share by Region (2027-2032) Table 34. Global Live Cell Imaging Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Live Cell Imaging Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Live Cell Imaging Software Sales Value Market Share by Country (2021-2026) Table 37. Global Live Cell Imaging Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Live Cell Imaging Software Sales Value Market Share by Country (2027-2032) Table 39. Andor Technology Company Information Table 40. Andor Technology Business Overview Table 41. Andor Technology Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Andor Technology Live Cell Imaging Software Product Portfolio Table 43. Andor Technology Recent Development Table 44. Fluxion Biosciences Company Information Table 45. Fluxion Biosciences Business Overview Table 46. Fluxion Biosciences Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Fluxion Biosciences Live Cell Imaging Software Product Portfolio Table 48. Fluxion Biosciences Recent Development Table 49. Olympus LS Company Information Table 50. Olympus LS Business Overview Table 51. Olympus LS Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Olympus LS Live Cell Imaging Software Product Portfolio Table 53. Olympus LS Recent Development Table 54. PerkinElmer Company Information Table 55. PerkinElmer Business Overview Table 56. PerkinElmer Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. PerkinElmer Live Cell Imaging Software Product Portfolio Table 58. PerkinElmer Recent Development Table 59. Sartorius Company Information Table 60. Sartorius Business Overview Table 61. Sartorius Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Sartorius Live Cell Imaging Software Product Portfolio Table 63. Sartorius Recent Development Table 64. Molecular Devices Company Information Table 65. Molecular Devices Business Overview Table 66. Molecular Devices Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Molecular Devices Live Cell Imaging Software Product Portfolio Table 68. Molecular Devices Recent Development Table 69. Phase Holographic Imaging PHI Company Information Table 70. Phase Holographic Imaging PHI Business Overview Table 71. Phase Holographic Imaging PHI Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Phase Holographic Imaging PHI Live Cell Imaging Software Product Portfolio Table 73. Phase Holographic Imaging PHI Recent Development Table 74. Agilent Company Information Table 75. Agilent Business Overview Table 76. Agilent Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Agilent Live Cell Imaging Software Product Portfolio Table 78. Agilent Recent Development Table 79. BioTek Company Information Table 80. BioTek Business Overview Table 81. BioTek Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. BioTek Live Cell Imaging Software Product Portfolio Table 83. BioTek Recent Development Table 84. Nanlive Company Information Table 85. Nanlive Business Overview Table 86. Nanlive Live Cell Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Nanlive Live Cell Imaging Software Product Portfolio Table 88. Nanlive Recent Development Table 89. CytoSMART Company Information Table 90. CytoSMART Business Overview Table 91. CytoSMART Live Cell Imaging Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. CytoSMART Live Cell Imaging Software Product Portfolio Table 93. CytoSMART Recent Development Table 94. AutoLCI Company Information Table 95. AutoLCI Business Overview Table 96. AutoLCI Live Cell Imaging Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. AutoLCI Live Cell Imaging Software Product Portfolio Table 98. AutoLCI Recent Development Table 99. MilliporeSigma Company Information Table 100. MilliporeSigma Business Overview Table 101. MilliporeSigma Live Cell Imaging Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. MilliporeSigma Live Cell Imaging Software Product Portfolio Table 103. MilliporeSigma Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Live Cell Imaging Software Product Image Figure 2. Global Live Cell Imaging Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Cell Imaging Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Live Cell Imaging Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On Premises Image Figure 9. Global Live Cell Imaging Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Live Cell Imaging Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Live Cell Imaging Software Sales Value Share by Type (2021-2032) Figure 12. Laboratory Image Figure 13. Hospital Image Figure 14. Others Image Figure 15. Global Live Cell Imaging Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Live Cell Imaging Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Live Cell Imaging Software Sales Value Share by Application (2021-2032) Figure 18. Global Live Cell Imaging Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Live Cell Imaging Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Live Cell Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Live Cell Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Live Cell Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Live Cell Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Live Cell Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Live Cell Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Live Cell Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Live Cell Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Live Cell Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Live Cell Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Live Cell Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On Premises
Applications
  • Laboratory
  • Hospital
  • Others
Companies covered
  • Andor Technology
  • Fluxion Biosciences
  • Olympus LS
  • PerkinElmer
  • Sartorius
  • Molecular Devices
  • Phase Holographic Imaging PHI
  • Agilent
  • BioTek
  • Nanlive
  • CytoSMART
  • AutoLCI
  • MilliporeSigma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Live Cell Imaging Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Live Cell Imaging Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Live Cell Imaging Software Market Dynamics
  1. 2.1 Live Cell Imaging Software Industry Trends
  2. 2.2 Live Cell Imaging Software Industry Drivers
  3. 2.3 Live Cell Imaging Software Industry Opportunities and Challenges
  4. 2.4 Live Cell Imaging Software Industry Restraints
3 Live Cell Imaging Software Market by Company
  1. 3.1 Global Live Cell Imaging Software Company Revenue Ranking in 2025
  2. 3.2 Global Live Cell Imaging Software Revenue by Company (2021-2026)
  3. 3.3 Global Live Cell Imaging Software Company Ranking (2024-2026)
  4. 3.4 Global Live Cell Imaging Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Live Cell Imaging Software Company Product Type and Application
  6. 3.6 Global Live Cell Imaging Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Live Cell Imaging Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Live Cell Imaging Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Live Cell Imaging Software Market by Type
  1. 4.1 Live Cell Imaging Software Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On Premises
  4. 4.2 Global Live Cell Imaging Software Sales Value by Type
  5. 4.2.1 Global Live Cell Imaging Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Live Cell Imaging Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Live Cell Imaging Software Sales Value Share by Type (2021-2032)
5 Live Cell Imaging Software Market by Application
  1. 5.1 Live Cell Imaging Software Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Live Cell Imaging Software Sales Value by Application
  6. 5.2.1 Global Live Cell Imaging Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Live Cell Imaging Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Live Cell Imaging Software Sales Value Share by Application (2021-2032)
6 Live Cell Imaging Software Regional Value Analysis
  1. 6.1 Global Live Cell Imaging Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Live Cell Imaging Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Live Cell Imaging Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Live Cell Imaging Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Live Cell Imaging Software Sales Value (2021-2032)
  7. 6.3.2 North America Live Cell Imaging Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Live Cell Imaging Software Sales Value (2021-2032)
  10. 6.4.2 Europe Live Cell Imaging Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Live Cell Imaging Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Live Cell Imaging Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Live Cell Imaging Software Sales Value (2021-2032)
  16. 6.6.2 South America Live Cell Imaging Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Live Cell Imaging Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Live Cell Imaging Software Sales Value Share by Country, 2025 VS 2032
7 Live Cell Imaging Software Country-level Value Analysis
  1. 7.1 Global Live Cell Imaging Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Live Cell Imaging Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Live Cell Imaging Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Live Cell Imaging Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Live Cell Imaging Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Live Cell Imaging Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Live Cell Imaging Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Andor Technology
  2. 8.1.1 Andor Technology Company Information
  3. 8.1.2 Andor Technology Business Overview
  4. 8.1.3 Andor Technology Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Andor Technology Live Cell Imaging Software Product Portfolio
  6. 8.1.5 Andor Technology Recent Developments
  7. 8.2 Fluxion Biosciences
  8. 8.2.1 Fluxion Biosciences Company Information
  9. 8.2.2 Fluxion Biosciences Business Overview
  10. 8.2.3 Fluxion Biosciences Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fluxion Biosciences Live Cell Imaging Software Product Portfolio
  12. 8.2.5 Fluxion Biosciences Recent Developments
  13. 8.3 Olympus LS
  14. 8.3.1 Olympus LS Company Information
  15. 8.3.2 Olympus LS Business Overview
  16. 8.3.3 Olympus LS Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Olympus LS Live Cell Imaging Software Product Portfolio
  18. 8.3.5 Olympus LS Recent Developments
  19. 8.4 PerkinElmer
  20. 8.4.1 PerkinElmer Company Information
  21. 8.4.2 PerkinElmer Business Overview
  22. 8.4.3 PerkinElmer Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PerkinElmer Live Cell Imaging Software Product Portfolio
  24. 8.4.5 PerkinElmer Recent Developments
  25. 8.5 Sartorius
  26. 8.5.1 Sartorius Company Information
  27. 8.5.2 Sartorius Business Overview
  28. 8.5.3 Sartorius Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sartorius Live Cell Imaging Software Product Portfolio
  30. 8.5.5 Sartorius Recent Developments
  31. 8.6 Molecular Devices
  32. 8.6.1 Molecular Devices Company Information
  33. 8.6.2 Molecular Devices Business Overview
  34. 8.6.3 Molecular Devices Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Molecular Devices Live Cell Imaging Software Product Portfolio
  36. 8.6.5 Molecular Devices Recent Developments
  37. 8.7 Phase Holographic Imaging PHI
  38. 8.7.1 Phase Holographic Imaging PHI Company Information
  39. 8.7.2 Phase Holographic Imaging PHI Business Overview
  40. 8.7.3 Phase Holographic Imaging PHI Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Phase Holographic Imaging PHI Live Cell Imaging Software Product Portfolio
  42. 8.7.5 Phase Holographic Imaging PHI Recent Developments
  43. 8.8 Agilent
  44. 8.8.1 Agilent Company Information
  45. 8.8.2 Agilent Business Overview
  46. 8.8.3 Agilent Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Agilent Live Cell Imaging Software Product Portfolio
  48. 8.8.5 Agilent Recent Developments
  49. 8.9 BioTek
  50. 8.9.1 BioTek Company Information
  51. 8.9.2 BioTek Business Overview
  52. 8.9.3 BioTek Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioTek Live Cell Imaging Software Product Portfolio
  54. 8.9.5 BioTek Recent Developments
  55. 8.10 Nanlive
  56. 8.10.1 Nanlive Company Information
  57. 8.10.2 Nanlive Business Overview
  58. 8.10.3 Nanlive Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nanlive Live Cell Imaging Software Product Portfolio
  60. 8.10.5 Nanlive Recent Developments
  61. 8.11 CytoSMART
  62. 8.11.1 CytoSMART Company Information
  63. 8.11.2 CytoSMART Business Overview
  64. 8.11.3 CytoSMART Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CytoSMART Live Cell Imaging Software Product Portfolio
  66. 8.11.5 CytoSMART Recent Developments
  67. 8.12 AutoLCI
  68. 8.12.1 AutoLCI Company Information
  69. 8.12.2 AutoLCI Business Overview
  70. 8.12.3 AutoLCI Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AutoLCI Live Cell Imaging Software Product Portfolio
  72. 8.12.5 AutoLCI Recent Developments
  73. 8.13 MilliporeSigma
  74. 8.13.1 MilliporeSigma Company Information
  75. 8.13.2 MilliporeSigma Business Overview
  76. 8.13.3 MilliporeSigma Live Cell Imaging Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MilliporeSigma Live Cell Imaging Software Product Portfolio
  78. 8.13.5 MilliporeSigma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst